0001231919-26-000240.txt : 20260309 0001231919-26-000240.hdr.sgml : 20260309 20260309110530 ACCESSION NUMBER: 0001231919-26-000240 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260309 DATE AS OF CHANGE: 20260309 EFFECTIVENESS DATE: 20260309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Covariance Labs Inc. CENTRAL INDEX KEY: 0002116173 ORGANIZATION NAME: EIN: 850813297 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-575815 FILM NUMBER: 26733690 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS SUITE 1720 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 9147210835 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS SUITE 1720 CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0708 D LIVE 0002116173 Covariance Labs Inc. 1350 AVENUE OF THE AMERICAS, SUITE 1720 NEW YORK NY NEW YORK 10019 9147210835 DELAWARE Covariance Labs LLC None Corporation true Michael Fleder c/o Covariance Labs Inc. 1350 Avenue of the Americas, Suite 1720 New York NY NEW YORK 10019 Executive Officer Director Thomas Jermoluk c/o Covariance Labs Inc. 1350 Avenue of the Americas, Suite 1720 New York NY NEW YORK 10019 Director Other Technology Decline to Disclose 06b false 2026-01-15 false true false 0 10999976 10999976 0 false 6 0 0 0 false Covariance Labs Inc. /s/Michael Fleder Michael Fleder Chief Executive Officer 2026-03-09